Abbreviated New Drug Application (ANDA)
-
Alembic Pharma receives USFDA approval for Chlorthalidone tabs USP, 25 mg and 50 mg
Diuretics such as chlorthalidone are indicated in the management of hypertension Alembic Pharmaceuticals has received final approval from the US…
Read More » -
Alembic Pharma bags US FDA approval for Dabigatran Etexilate capsules
Dabigatran Etexilate capsules are indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation…
Read More » -
Alembic’s JV Aleor Dermaceuticals bags US FDA approval for Mupirocin Cream
Mupirocin Cream is indicated for the treatment of traumatic skin lesion cream Alembic Pharmaceuticals’ joint venture Aleor Dermaceuticals (Aleor) has…
Read More » -
Dr Reddy’s Laboratories’ Lenalidomide caps gets US FDA approval
Dr Reddy’s is eligible for 180 days of generic drug exclusivity for Lenalidomide capsules, 2.5 mg and 20 mg Dr…
Read More » -
Cipla receives final approval for generic version of GSK’s IMITREX
Cipla Gulf expands partnership with Alvotech for commercialisation of biosimilars in Australia and New Zealand Cipla has received final approval…
Read More »
